Images: Caffeine therapy for central sleep apnea, hypoxemia, and hypoventilation in a term neonate

• Published in: Journal of clinical sleep medicine 2023-05, Vol.19 (5), p.1005-1008
• Main Authors: Shah, Amit S, Leu, Roberta M, Shah, Samar P, Martinez, Frances, Kasi, Ajay S
• Format: Article
• Language: English
• Subjects: Caffeine; Humans; Hypoventilation; Hypoxia; Infant; REM: A Publication for Residents and Fellows; Sleep Apnea, Central; Sleep Apnea, Obstructive - therapy
• ISSN: 1550-9389; 1550-9397
• DOI: 10.5664/jcsm.10504

The evaluation of higher-risk infants with brief resolved unexplained events and term infants with central sleep apnea can be clinically challenging due to the multitude of potential etiologies. We report a 7-day-old term neonate hospitalized for evaluation of brief resolved unexplained events with oxygen desaturations during sleep. Polysomnography showed central sleep apnea, hypoxemia, hypoventilation, periodic breathing, and mild obstructive sleep apnea. Following initial evaluations and while awaiting genetic testing, primary central sleep apnea of infancy was suspected and caffeine was initiated. Three days after initiating caffeine, polysomnography showed resolution of hypoxemia, hypoventilation, obstructive sleep apnea, and periodic breathing and improved central sleep apnea. The central apnea-hypopnea index reduced from 58 to 6.8 events/h. Although caffeine is utilized in apnea of prematurity, there is limited literature regarding caffeine in term infants with apnea. Our case demonstrates that in term infants with primary central sleep apnea of infancy, immature regulation of respiration may persist and a trial of caffeine could be considered. Shah AS, Leu RM, Shah SP, Martinez F, Kasi AS. Caffeine therapy for central sleep apnea, hypoxemia, and hypoventilation in a term neonate. . 2023;19(5):1005-1008.